Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.

Fenichel GM, Florence JM, Pestronk A, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Robison J, King W, et al.

Neurology. 1991 Dec;41(12):1874-7.

PMID:
1745340
[PubMed - indexed for MEDLINE]
2.

Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP.

Arch Neurol. 1991 Apr;48(4):383-8.

PMID:
2012511
[PubMed - indexed for MEDLINE]
3.

Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.

Brooke MH, Fenichel GM, Griggs RC, Mendell JR, Moxley RT 3rd, Miller JP, Kaiser KK, Florence JM, Pandya S, Signore L, et al.

Arch Neurol. 1987 Aug;44(8):812-7.

PMID:
3632393
[PubMed - indexed for MEDLINE]
4.

Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.

Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, King W, Signore L, Pandya S, Florence J, et al.

N Engl J Med. 1989 Jun 15;320(24):1592-7.

PMID:
2657428
[PubMed - indexed for MEDLINE]
5.

Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months)

Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP, Cwik VA, Pandya S, Robison J, et al.

Neurology. 1993 Mar;43(3 Pt 1):520-7.

PMID:
8450994
[PubMed - indexed for MEDLINE]
6.

Prednisone treatment in Duchenne muscular dystrophy. Long-term benefit.

DeSilva S, Drachman DB, Mellits D, Kuncl RW.

Arch Neurol. 1987 Aug;44(8):818-22.

PMID:
3632394
[PubMed - indexed for MEDLINE]
7.

Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study.

Reitter B.

Brain Dev. 1995;17 Suppl:39-43.

PMID:
8882570
[PubMed - indexed for MEDLINE]
8.

A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy.

Fenichel GM, Mendell JR, Moxley RT 3rd, Griggs RC, Brooke MH, Miller JP, Pestronk A, Robison J, King W, Signore L, et al.

Arch Neurol. 1991 Jun;48(6):575-9.

PMID:
2039377
[PubMed - indexed for MEDLINE]
9.

High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.

Connolly AM, Schierbecker J, Renna R, Florence J.

Neuromuscul Disord. 2002 Dec;12(10):917-25.

PMID:
12467746
[PubMed - indexed for MEDLINE]
10.

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Moxley RT 3rd, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society.

Neurology. 2005 Jan 11;64(1):13-20.

PMID:
15642897
[PubMed - indexed for MEDLINE]
11.

Low-dose prednisolone treatment in Duchenne and Becker muscular dystrophy.

Bäckman E, Henriksson KG.

Neuromuscul Disord. 1995 May;5(3):233-41.

PMID:
7633189
[PubMed - indexed for MEDLINE]
12.

Corticosteroid therapy in Duchenne muscular dystrophy.

Khan MA.

J Neurol Sci. 1993 Dec 1;120(1):8-14. Review.

PMID:
8289083
[PubMed - indexed for MEDLINE]
13.

Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.

Kissel JT, Burrow KL, Rammohan KW, Mendell JR.

Neurology. 1991 May;41(5):667-72.

PMID:
2027481
[PubMed - indexed for MEDLINE]
14.

Profiles of neuromuscular diseases. Duchenne muscular dystrophy.

McDonald CM, Abresch RT, Carter GT, Fowler WM Jr, Johnson ER, Kilmer DD, Sigford BJ.

Am J Phys Med Rehabil. 1995 Sep-Oct;74(5 Suppl):S70-92.

PMID:
7576424
[PubMed - indexed for MEDLINE]
15.

Selenium and vitamin E treatment of Duchenne muscular dystrophy: no effect on muscle function.

Bäckman E, Nylander E, Johansson I, Henriksson KG, Tagesson C.

Acta Neurol Scand. 1988 Nov;78(5):429-35.

PMID:
3218450
[PubMed - indexed for MEDLINE]
16.

Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group.

Burrow KL, Coovert DD, Klein CJ, Bulman DE, Kissel JT, Rammohan KW, Burghes AH, Mendell JR.

Neurology. 1991 May;41(5):661-6.

PMID:
1781820
[PubMed - indexed for MEDLINE]
17.

Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine.

Mendell JR, Griggs RC, Moxley RT 3rd, Fenichel GM, Brooke MH, Miller JP, Province MA, Dodson WE.

Muscle Nerve. 1984 Sep;7(7):535-41.

PMID:
6399927
[PubMed - indexed for MEDLINE]
18.

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule.

Sansome A, Royston P, Dubowitz V.

Neuromuscul Disord. 1993 Sep-Nov;3(5-6):567-9.

PMID:
8186713
[PubMed - indexed for MEDLINE]
19.

[Glucocorticoid therapy in Duchenne muscular dystrophy].

Kang J.

Rinsho Shinkeigaku. 1996 Dec;36(12):1338-40. Japanese.

PMID:
9128400
[PubMed - indexed for MEDLINE]
20.

Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial.

Beenakker EA, Fock JM, Van Tol MJ, Maurits NM, Koopman HM, Brouwer OF, Van der Hoeven JH.

Arch Neurol. 2005 Jan;62(1):128-32.

PMID:
15642859
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk